Norinchukin Bank’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,643
Closed -$649K 558
2022
Q3
$649K Buy
2,643
+146
+6% +$39.4K 0.01% 444
2022
Q2
$618K Sell
2,497
-1,597
-39% -$431K 0.01% 453
2022
Q1
$1.36M Buy
4,094
+210
+5% +$64.6K 0.02% 404
2021
Q4
$1.4M Sell
3,884
-17
-0.4% -$5.74K 0.02% 381
2021
Q3
$1.27M Buy
3,901
+157
+4% +$53.2K 0.02% 392
2021
Q2
$1.17M Sell
3,744
-18
-0.5% -$5.52K 0.02% 398
2021
Q1
$1.2M Buy
3,762
+62
+2% +$19.8K 0.02% 381
2020
Q4
$1.2M Sell
3,700
-80
-2% -$22.1K 0.02% 354
2020
Q3
$1.05M Buy
3,780
+51
+1% +$14.7K 0.02% 355
2020
Q2
$901K Sell
3,729
-50
-1% -$10K 0.02% 361
2020
Q1
$549K Sell
3,779
-2,201
-37% -$365K 0.01% 407
2019
Q4
$1.02M Sell
5,980
-542
-8% -$100K 0.01% 454
2019
Q3
$1.16M Buy
6,522
+171
+3% +$37K 0.02% 444
2019
Q2
$1.65M Sell
6,351
-2,173
-25% -$577K 0.03% 370
2019
Q1
$2.43M Buy
8,524
+314
+4% +$104K 0.03% 343
2018
Q4
$2.67M Buy
8,210
+2,439
+42% +$847K 0.04% 287
2018
Q3
$2.6M Buy
5,771
+984
+21% +$388K 0.04% 261
2018
Q2
$1.96M Buy
+4,787
New +$1.73M 0.03% 290

Other funds holding ABMD

Norinchukin Bank's ABMD Position: Q4 2022 in Review

Norinchukin Bank sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,643 shares — an estimated $649K sold.

Norinchukin Bank first reported a position in ABMD in Q2 2018 and held it in 18 quarters. The position peaked at $2.67M in Q4 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Norinchukin Bank reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Norinchukin Bank sold 2,643 Abiomed Inc shares in Q4 2022, an estimated $649K.
  • Norinchukin Bank first reported a position in Abiomed Inc in Q2 2018 and held it in 18 quarters.
  • Norinchukin Bank's Abiomed Inc position peaked at $2.67M in Q4 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Norinchukin Bank's 13F filing for Q4 2022, filed 13 Feb 2023.